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Abstract 
The present study defines a new statistic for detecting laboratory effects in the analysis of ordinal 
variation (ORDANOVA). The ORDANOVA is an analysis method similar to one-way analysis of 
variance for analysing ordinal data obtained from interlaboratory comparison studies. In this paper, 
we present an approximate continuous distribution for the new statistic for the case of an arbitrary 
number of ordinal levels, and we demonstrate that a-percentiles of the distribution are suitable 
criteria for conducting statistical tests. In addition, a real example involving data from an 
interlaboratory comparison study is analysed using the proposed statistic. 
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1. Introduction 
Interlaboratory comparison studies are conducted to validate new measurement and test methods; 
one of the primary aims of these studies is to verify whether laboratory effects exist. ISO 5725 Parts 
1 and 2 [6, 7] describe how to organise such studies and analyse the obtained results. Specially, Part 
2 uses one-way analysis of variance (ANOVA) to detect laboratory effects for quantitative data.  
 
Interlaboratory comparison studies occasionally generate qualitative data. For example, studies that 
involve animals and include histopathological examinations provide ordinal data as the results. In 
histopathological examination, pathology experts use microscopes to observe tissue samples of 
experimental animals after administering substances to those animals. From the observation results, 
the experts rate the effect levels for each animal and each observation item using integers and plus 
and minus signs. To conduct ANOVA-like analyses for ordinal data, Gadrich and Bashkansky [5] 
proposed the analysis of ordinal variation (ORDANOVA). They also defined a test statistic for 
detecting laboratory effects for an arbitrary number of ordinal levels; however, the approximate 
distribution of the statistic was determined only for two ordinal levels.  
 
The aim of the present study is to develop a new test statistic for detecting laboratory effects in 
ORDANOVA and to determine its approximate distribution for an arbitrary number of ordinal 
levels. The new test statistic is applied to the results of an interlaboratory comparison study 
involving intratracheal administration testing reported in AIST [1]; these results comprise ordinal 
data with five levels. 
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2. Preliminaries 
In this section, we summarise the ORDANOVA; see also Bashkansky, et al. [2]. Let M be the 
number of laboratories participating in an interlaboratory comparison study and K be the number of 
categories used in the study. Each laboratory is coded by an integer  and has n 
measurement results. In addition, each category is coded by an integer , and the codes 
are used for expressing each obtained result. It should be noted that the number of measurement 
results are assumed to be identical for all laboratories in the present study. The following notation is 
used: 
• : number of measurement results belonging to the kth category at laboratory m. Note that 
 holds for any m. 
• : percentage of measurement results belonging to the kth category at laboratory m. In other 
words,  
• : mean of  with respect to m. 
• : cumulative percentage of the measurement results belonging up to the kth category at 
laboratory m. In other words, . 
• : mean of  with respect to m. 
 
Previous studies [2], [5] have defined the total ordinal variation in interlaboratory comparison, 
 
 ,  (1) 
 
as well as the ordinal within-laboratory variation for the mth laboratory, 
 
  (2) 
 
and the classic variation of the cumulative frequencies up to the kth category between laboratories, 
 
   (3) 
It should be noted that these definitions were the most successful measure of a population data 
variation, which was proposed by Blaia and Lacy [3]. 
 
Under the null hypothesis , the studies introduced the 
following relationship: 
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k ∈ 1,…,K{ }
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   (4) 
Here,  represents the average of all within-laboratory ordinal variation, while represents a 
measure of the average of all between-laboratory variation.  
 
In addition, studies [5] and [2] defined the following test statistic, , for detecting laboratory 
effects: 
   (5) 
where  degrees of freedom and  degrees of freedom.  
 
Finally, under the null hypothesis , it was demonstrated 
that the test statistic  approximately followed  when the number of categories was 
. However, for , the following criteria were proposed for detecting laboratory effects: 
(1) When , reject . 
(2) When , accept . 
(3)  is a region of doubt. 
However, no approximate distribution of  has been verified for . 
  
3. Results 
In this section, we define a new test statistic for detecting laboratory effects of ORDANOVA, and 
we determine the approximate distribution of the statistic for an arbitrary number of categories. 
 
Definition  
A test statistic, , for detecting laboratory effects for ORDANOVA is defined as follows: 
  
 
Theorem 
Under the null hypothesis , test statistic  
approximately follows a normal distribution with mean  and variable , where 
   
  
 
Proof 
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From null hypothesis , we assume that  for any laboratory m, 
where MN denotes a multi-normal distribution. 
 
First, we approximate the multi-nominal distribution by a multi-normal distribution. Let 
 where 
  
Then, for any laboratory m, any number of measurement results n and , we can consider 
 a vector of probability variables that follows the multi-normal distribution 
.  
 
Next, we obtain 
   (6) 
  
and 
   (7) 
We then have  
  (8) 
  
Since  for any m, we obtain  
  (9) 
for any m. 
 
Thus, the following holds:  
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 . (10) 
  
This completes the proof.  
 
4. Application  
 
In this section, we analyse the results of an interlaboratory comparison study reported in AIST [1]. 
The study was conducted to assess the accuracy of intratracheal administration testing [4], which is 
an in vivo screening method for evaluating the pulmonary toxicity of nanomaterials [9]. The study 
consisted of five laboratories, each of which examined 19 pathological findings using five rats and 
reported one of the following scores for each finding and each rat:  and . Here score 
indicates that the rat had no effect on the focused findings, whereas scores  and  
indicate that the rat did have an effect on the focused findings. Scores  and  represent the 
weakest and strongest effects, respectively.  
 
This section addresses two of the 19 pathological findings and analyses the results after scores 
 and  are converted to category numbers 1, 2, 3, 4 and 5, respectively. 
 
Because  and , the proposed test statistic becomes 
, 
 
and, under the null hypothesis , 
 
We note that the value of  is unknown in real examples; therefore, the estimation  is used 
instead. The mean value of  with respect to the laboratories is used as the estimation .  
 
Table 1 presents the results of the interlaboratory comparison study on the appearance of alveolar 
macrophages following the administration of 0.13mg/kg weight of a multiwall carbon nanotube 
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(MWCNT). In this case,  and the upper fifth percentile of the normal distribution is 
0.646; this demonstrates that there is no laboratory effect. Table 2 presents the results of a study on 
hyperplasia of type II pneumocytes following the administration of 0.13mg/kg weight of MWCNT. 
In this case,  and the upper fifth percentile of the normal distribution is 1.04. This 
demonstrates that there is a laboratory effect. Thus, intratracheal administration testing differs 
among laboratories for some of the pathological findings. This result suggests that the intratracheal 
administration testing procedure may require stricter standardisation. 
 
It should be noted that this conclusion is from a statistical viewpoint only; evaluation from the 
viewpoint of toxicology is important for in vivo testing procedures. The proposed method can 
therefore provide useful information for discussing the accuracy of in vivo testing procedures; 
however, a final judgement for in vivo testing procedures should be made via a comprehensive 
discussion. 
 
Table 1: Results of a comparison study on the appearance of alveolar macrophages following the 
administration of 0.13mg/kg weight of MWCNT, reported in AIST [1]. 
Lab 
# of rats reported in each category 
1 2 3 4 5 
Lab A 0 0 0 5 0 
Lab B 0 0 1 4 0 
Lab C 0 3 2 0 0 
Lab D 0 0 5 0 0 
Lab E 0 2 2 1 0 
 
Table 2: Results of a comparison study on hyperplasia of type II pneumocytes following the administration 
of 0.13mg/kg weight of MWCNT, reported in AIST [1]. 
Lab 
# of rats reported in each category 
1 2 3 4 5 
Lab A 0 0 1 4 0 
Lab B 3 0 1 1 0 
Lab C 3 2 0 0 0 
Lab D 1 0 4 0 0 
Lab E 3 1 1 0 0 
 
 
5. Discussion 
5.1. Proposed test statistic 
 
In this subsection, we compare the exact distribution derived by a computer simulation and the 
approximate distribution proposed in Section 4 for two cases: (a)  and (b) 
. 
 
For cases (a) and (b), each number of laboratories  and each number of 
measurements in each laboratory . The following procedure was conducted to 
I(N ) = 0.544
I(N ) = 1.88
p1 = p2 = p3 = 1/ 3
p1 = 3/ 6, p2 = 1/ 2, p3 = 2 / 6
M ∈ 5,10,20{ }
n∈ 5,10,20{ }
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produce the exact distribution of . We note that the following analyses were performed using 
Mathematica 11.2 (Wolfram Research, Illinois). 
(1) For each , sample of a random variable pair  that follows the 
multi-nominal distribution . 
(2) Calculate the test statistic . 
(3) Repeat procedures (1)–(2) 10,000 times. 
(4)  
The approximate distribution , in contrast, is calculated using the Theorem, and it is denoted by 
.  
 
Figure 1 andFigure 2 present cumulative histograms of  and the distribution function of . 
In each figure, the bars and blue line represent  and , respectively, whereas the horizontal 
and vertical axes represent the values of the test statistics and the cumulative probabilities, 
respectively. Only several differences exist between  and ; therefore,  sufficiently 
approximates the test statistic . In addition, Table 3 illustrates the upper fifth percentiles of 
 and , whereas Table 4 illustrates the relative errors of  for the upper fifth percentile 
in cases (a) and (b). It can be seen that the relative errors decrease when the number of laboratories 
and repetitions increases. However, the values of the upper fifth percentiles are almost identical 
between  and , and the relative errors of  for  are less than 0.02. Therefore, we 
conclude that the approximate continuous distribution  can be used to conduct statistical tests 
for detecting laboratory effects. To detect laboratory effects with a 5% significance level, the upper 
fifth percentile of the normal distribution  should be used. 
 
I(N )
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I(N )
A
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Figure 1: Yellow bars are cumulative histograms of , whereas blue lines represent the distribution 
function of  in case (a). In each plot, the horizontal axis represents the values of the test statistics, 
whereas the vertical axis represents the cumulative probabilities. 
 
I S (N )
I(N )
A
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Figure 2: Yellow bars are the cumulative histograms of , whereas blue lines represent the distribution 
function of  in case (b). In each plot, the horizontal axis represents the values of the test statistics, 
whereas the vertical axis represents the cumulative probabilities. 
 
Table 3: Upper fifth percentiles of the exact distribution by simulation, , and the approximate 
distribution,  and the relative error of  for  for case (a) . 
# of labs # of repetitions 
Upper fifth percentile Relative error of  for  
   
5 5 1.45 1.43 0.014 
5 10 1.29 1.27 0.016 
5 20 1.06 1.06 0.000 
10 5 1.29 1.27 0.016 
10 10 1.15 1.16 0.009 
10 20 1.01 1.01 0.000 
20 5 1.15 1.16 0.009 
20 10 1.08 1.08 0.000 
20 20 0.97 0.97 0.000 
 
I S (N )
I(N )
A
I S (N )
I(N )
A I(N )
A I S (N ) p1 = p2 = p3 = 1/ 3
I(N )
A I S (N )
I S (N ) I(N )
A I(N )
A − I(N )
S / I(N )
S
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Table 4: Upper fifth percentiles of the exact distribution by simulation, , and the approximate 
distribution,  and the relative error of  for  for case (b) . 
# of labs # of repetitions 
Upper fifth percentile Relative error of  for  
   
5 5 1.57 1.54 0.019 
5 10 1.37 1.36 0.007 
5 20 1.13 1.13 0.000 
10 5 1.37 1.36 0.007 
10 10 1.25 1.24 0.008 
10 20 1.08 1.08 0.000 
20 5 1.25 1.24 0.008 
20 10 1.15 1.15 0.000 
20 20 1.04 1.04 0.000 
 
5.2. Previous studies  
 
When the significance level is set to 5%, the present study proposes to use the upper fifth percentile 
of the approximate distribution  for . The previous study [5], however, proposed to use a 
constant number, 3, as the criterion for detecting laboratory effects. In this subsection, we discuss 
these criteria as follows. 
 
For cases (a) and (b), each number of laboratories  and each number of 
measurements in each laboratory , the following procedure was conducted to produce 
the exact distribution of  and calculate the upper fifth percentile of . We note that the 
following analyses were performed using Mathematica 11.2 (Wolfram Research, Illinois). 
(1) For each ,sample a random variable pair  that follows the multi-
nominal distribution . 
(2) Calculate the statistic . 
(3) Repeat procedures (1)–(2) 10,000 times. 
(4)  
(5) Calculate the value at the top of 5% in the set of , which is denoted by . 
 
Figure 3 presents a cumulative histogram of  and the constant, 3. In each plot, the horizontal 
and vertical axes represent the values of the test statistics and the cumulative probabilities, 
respectively, for case (a). Figure 4 presents the same information as Figure 3, but for case (b). If the 
y-axis values of the intersection points between the red lines and histograms equal approximately 
I S (N )
I(N )
A I(N )
A I S (N ) p1 = 3/ 6, p2 = 1/ 2, p3 = 2 / 6
I(N )
A I S (N )
I S (N ) I(N )
A I(N )
A − I(N )
S / I(N )
S
I(N )
A I(N )
M ∈ 5,10,20{ }
n∈ 5,10,20{ }
I(P) I(P)
i∈{1,…,M} (X1i ,X2i ,X3i )
MN(n; p1, p2 , p3)
I(P)
I(P)
s := I(P){ }
I(P)
S I(P),0.05
S
I S (P)
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0.95, then the criterion, 3, proposed in the previous study succeeds in detecting laboratory effects 
with a 5% significance level.  
 
Table 5 illustrates , the relative error of the constant, 3, for  and the percentage of the 
area  for case (a). Table 6 presents the same information as Table 5, but for case 
(b). The constant, 3, is much larger than  for all cases. In addition, the percentages of area 
 are considerably smaller than  for all cases. We therefore conclude that 
the constant, 3, is too strict of a criterion for detecting laboratory effects when the number of 
categories is . 
 
 
Figure 3: Yellow bars are cumulative histograms of , whereas red lines indicate the constant, 3, for 
case (a). ). In each plot, the horizontal axis represents the values of the test statistics, whereas the vertical 
axis represents the cumulative probabilities. 
 
 
I(P),0.05
S I(P),0.05
S
{I(P) ∈I(P)
S | I(P) ≥ 3}
I S (P),0.05
{I(P) ∈I(P)
S | I(P) ≥ 3} I(P),0.05
S
K = 3
I S (P)
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Figure 4: Yellow bars are cumulative histograms of , whereas red lines indicate the constant, 3, for 
case (b). ). In each plot, the horizontal axis represents the values of the test statistics, whereas the vertical 
axis represents the cumulative probabilities. 
 
 
Table 5: Upper fifth percentiles of the exact distribution by simulation, , the relative error of the 
constant, 3, for the upper fifth percentiles and the percentage of area  in case (a) 
. 
# of labs # of repetitions 
Upper fifth 
percentile of 
,  
Relative error of 
 for 3
 
Percentage of the 
area 
 
(%) 
5 5 1.95 0.538  0.23 
5 10 2.02 0.485  0.31 
5 20 2.05 0.463  0.53 
10 5 1.60 0.875  0.00 
10 10 1.66 0.807  0.00 
10 20 1.70 0.765  0.04 
20 5 1.40 1.143  0.00 
20 10 1.44 1.083  0.00 
I S (P)
I S (P)
{I(P) ∈I(P)
S | I(P) ≥ 3}
p1 = p2 = p3 = 1/ 3
I S (P) I
S
(P),0.05
I S (P),0.05
3− I(P),0.05
S / I(P),0.05
S
{I(P) ∈I(P)
s | I(P) ≥ 3}
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20 20 1.46 1.055  0.00 
 
Table 6: Upper fifth percentiles of the exact distribution by simulation, , the relative error of the 
constant, 3, for the upper fifth percentiles and the percentage of area  in case 
 in (b) . 
# of labs # of repetitions 
Upper fifth 
percentile of 
,  
Relative error of 
 for 3 
 
Percentage of the 
area  
 
(%) 
5 5 2.05 0.463  0.512  0.33 
5 10 2.10 0.429  0.524  0.68 
5 20 2.13 0.408  0.531  0.97 
10 5 1.67 0.796  0.401  0.00 
10 10 1.71 0.754  0.415  0.02 
10 20 1.74 0.724  0.425  0.04 
20 5 1.45 1.069  0.310  0.00 
20 10 1.48 1.027  0.324  0.00 
20 20 1.50 1.000  0.333  0.00 
 
6. Conclusions 
 
In the present study, we defined a new test statistic for detecting laboratory effects in ORDANOVA 
and introduced its approximate multi-normal distribution for an arbitrary number of categories. 
Using the -percentile of the distribution, statistical tests can be conducted to detect laboratory 
effects. In addition, we analysed the results of an interlaboratory comparison study on intratracheal 
administration testing as a real example. Furthermore, we discussed the accuracy of the results of 
the present study and previous studies. The discussion in Section 5 suggests that the -percentile 
of the approximate multi-normal distribution in the present study is effective for conducting 
statistical tests to detect laboratory effects. In contrast, the results of the previous study may not be 
effective when the number of categories is . Thus, our method is more suitable for analysing 
categorical results from interlaboratory comparison studies, especially when there are more than 
three categories.  
 
In the present study, we focused solely on ORDANOVA for analysing the categorical results 
obtained from interlaboratory comparison studies. However, methods other than ORDANOVA 
have been proposed for categorical or binary results. For example, Wilrich [11] and Langton, et al. 
[8] have proposed ISO 5725-based methods, whereas van Wieringen and de Mast [10] have 
developed a Gauge R&R-based method. However, these studies only address the case of two 
categories. Hence, further studies are necessary to extend these methods to be able to apply three 
categories or more and to compare the methods with our proposed method. 
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S
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S
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S
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α
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